Induction of immune cell infiltration into murine SCCVII tumour by photofrin-based photodynamic therapy.

Cellular populations in the squamous cell carcinoma SCCVII, growing in C3H/HeN mice given Photofrin, were examined at various time intervals during the photodynamic light treatment and up to 8 h later. Cell populations present within excised tumours were identified by monoclonal antibodies directed against cell type-specific membrane markers using a combination of the indirect immunoperoxidase and Wright staining or by flow cytometry. Photofrin-based photodynamic therapy (PDT) induced dramatic changes in the level of different cellular populations contained in the treated tumour. The most pronounced was a rapid increase in the content of neutrophils, which increased 200-fold within 5 min after the initiation of light treatment. This was followed immediately by an increase in the levels of mast cells, while another type of myeloid cells, most likely monocytes, invaded the tumour between 0 and 2 h after PDT. The examination of cytolysis of in vitro cultured SCCVII tumour cells mediated by macrophages harvested from the SCCVII tumour revealed a pronounced increase in the tumoricidal activity of tumour-associated macrophages isolated at 2 h post PDT. It seems, therefore, that the PDT-induced acute inflammatory infiltration of myeloid cells into the treated tumour is associated with functional activation of immune cells.

[1]  N. Yamamoto,et al.  Activation of mouse macrophages by alkylglycerols, inflammation products of cancerous tissues. , 1988, Cancer research.

[2]  A. Girotti,et al.  Singlet oxygen intermediacy in the photodynamic action of membrane-bound hematoporphyrin derivative. , 1987, Cancer letters.

[3]  M. Korbelik,et al.  Distribution of Photofrin between tumour cells and tumour associated macrophages. , 1991, British Journal of Cancer.

[4]  B. Henderson,et al.  Release of prostaglandin E2 from cells by photodynamic treatment in vitro. , 1989, Cancer research.

[5]  M. Korbelik,et al.  Potentiation of photodynamic therapy by immunotherapy: the effect of schizophyllan (SPG). , 1994, Cancer letters.

[6]  H. Morris,et al.  Ether-lipids, -glycerol phosphate dehydrogenase, and growth rate in tumors and cultured cells. , 1972, Cancer research.

[7]  T. Mang,et al.  Tumor destruction and kinetics of tumor cell death in two experimental mouse tumors following photodynamic therapy. , 1985, Cancer research.

[8]  M. Korbelik,et al.  Distribution of disulfonated and tetrasulfonated aluminum phthalocyanine between malignant and host cell populations of a murine fibrosarcoma. , 1993, Journal of Photochemistry and Photobiology. B: Biology.

[9]  D. Bellnier.  Potentiation of photodynamic therapy in mice with recombinant human tumor necrosis factors-α , 1991 .

[10]  P B Cerrito,et al.  The role of microvascular damage in photodynamic therapy: the effect of treatment on vessel constriction, permeability, and leukocyte adhesion. , 1992, Cancer research.

[11]  H. Lim.  Role mediators of inflammation and cells in porphyrin-induced phototoxicity , 1989 .

[12]  Hedy E. Larkin,et al.  Phospholipase activation triggers apoptosis in photosensitized mouse lymphoma cells. , 1993, Cancer research.

[13]  R. Straight,et al.  SYSTEMIC IMMUNOSUPPRESSION INDUCED BY PHOTODYNAMIC THERAPY (PDT) IS ADOPTIVELY TRANSFERRED BY MACROPHAGES , 1989, Photochemistry and photobiology.

[14]  Vasile F. Dima,et al.  Treatment of rat Walker-256 carcinosarcoma with photodynamic therapy and endotoxin irradiated with high-energy electrons , 1994, Other Conferences.

[15]  R. Humphries,et al.  Identification and characterization of 114/A10, an antigen highly expressed on the surface of murine myeloid and erythroid progenitor cells and IL-3-dependent cell lines. , 1989, Experimental hematology.

[16]  N. Yamamoto,et al.  Activation of mouse peritoneal macrophages by lysophospholipids and ether derivatives of neutral lipids and phospholipids. , 1987, Cancer research.

[17]  H. Pass,et al.  Photodynamic therapy in oncology: mechanisms and clinical use. , 1993, Journal of the National Cancer Institute.

[18]  Mladen Korbelik,et al.  ENHANCED MACROPHAGE CYTOTOXICITY AGAINST TUMOR CELLS TREATED WITH PHOTODYNAMIC THERAPY , 1994, Photochemistry and photobiology.

[19]  J. Farber,et al.  Accelerated phospholipid degradation and associated membrane dysfunction in irreversible, ischemic liver cell injury. , 1978, The Journal of biological chemistry.

[20]  Paola Taroni,et al.  Antitumor immunity induced by photodynamic therapy with aluminum disulfonated phthalocyanines and laser light , 1994, Anti-cancer drugs.

[21]  N. Yamamoto,et al.  TUMORICIDAL CAPACITIES OF MACROPHAGES PHOTODYNAMICALLY ACTIVATED WITH HEMATOPORPHYRIN DERIVATIVE , 1992, Photochemistry and photobiology.

[22]  F. Kerdel,et al.  In vivo mediator release and degranulation of mast cells in hematoporphyrin derivative-induced phototoxicity in mice. , 1987, The Journal of investigative dermatology.